Free dog bite treatment is available at Aam Aadmi Clinics across Punjab, giving residents access to prompt medical care without the burden of treatment costs. As part of the state government's broader ...

Lunsumio VELO, a subcutaneous CD20xCD3 bispecific antibody, is approved for relapsed or refractory follicular lymphoma after two systemic therapies. The GO29781 study reported a 75% objective response ...

The shift toward dual-targeting bispecifics and the imminent arrival of highly efficacious triple combinations could shift the follicular lymphoma treatment space. The future treatment landscape for ...

A dog suffering from a severe injury receives incredible treatment, giving it a second chance at a happy life. Veterinarians and caregivers work tirelessly to provide the best care, showcasing the ...

Dr Kami Maddocks shares highlights from ASH 2025, including how the phase 3 EPCORE FL‑1 trial, adding a bispecific antibody to R2 in second‑line or later follicular lymphoma, showed significantly ...

Asymptomatic patients diagnosed with nonbulky follicular lymphoma, a slow-growing type of non-Hodgkin lymphoma, have traditionally been watched for signs or symptoms of disease progression and then ...

Dog bites are more common than people realize, even among people who love and understand dogs. In fact, in the United States, an estimated 4.5 million people are bitten by dogs every year, and nearly ...

Andrew Zelenetz, MD, PhD, discusses how patient characteristics and disease history play into treatment strategy for follicular lymphoma. The decision to use newer agents in relapsed/refractory ...

How a loyal dog stayed by its owner’s side through a tough medical treatment. US Open asks broadcasters not to show criticism of Donald Trump during men’s final Winning numbers announced for estimated ...

Christina Poh, MD, explores tafasitamab's universal benefits for follicular lymphoma treatment, highlighting its practical adoption and safety for all patients. In an interview with Targeted Oncology, ...